Seminar at The Ebola Forum, Rutgers University

Kartik spoke at this symposium organized by the working group, "Zoonosis and Society: Interdisciplinary Perspectives of Animal-to-Human Disease" at Rutgers University. Its goal was to integrate the diverse perspectives of sociologists, anthropologists, epidemiologists, ecologists, clinical researchers, and molecular virologists on the Ebola outbreak in West Africa. Watch the video of Kartik's talk (34 minutes).

Researchers Study Ebola Link to Gene in Rare Disease


The Wall Street Journal interviews Kartik and Chandran Lab collaborator Steven Walkley about the connection between the rare genetic disease Niemann-Pick Type C and Ebola virus. Our research raises the possibility that a mutated NPC1 gene offers protection against Ebola infection, just as carriers of sickle-cell disease are protected against malaria. (subscription only)

More coverage on this story at The Scientist and


Einstein Helps Establish $28 Million Consortium To Find Ebola Treatment

einsteinmonty logo.png

The National Institutes of Health (NIH) has awarded a five-year, $28 million grant for a new center for excellence, the 'Viral Hemorrhagic Fever Immunotherapeutic Consortium', that will discover antibody “cocktails” against filoviruses and arenaviruses. The project involves researchers from 15 institutions, including Kartik and a close collaborator at Einstein, Jonathan Lai. Read the press release.

Researchers Find "Key" Used by Ebola Virus to Unlock Cells and Spread Deadly Infection

Kartik and his collaborators, Thijn Brummelkamp (Netherlands Cancer Institute), John Dye (USAMRIID), and Sean Whelan (Harvard Medical School) have identified a cellular protein, NPC1, that is critical for infection by Ebola virus. This work was published in the August 24 online edition of Nature. See accompaning presser and watch the video.